Dianaty Ali 4
4 · MiniMed Group, Inc. · Filed Mar 13, 2026
Research Summary
AI-generated summary of this filing
MiniMed (MMED) EVP Dianaty Ali Receives 191,258-Share RSU Award
What Happened
- Dianaty Ali, EVP & Chief Product & Technology Officer of MiniMed Group, received a total of 191,258 restricted stock units (RSUs) on March 11, 2026. These awards were granted as part of the conversion of previously held Medtronic restricted stock units and performance share units into MMED RSUs under the Employee Matters Agreement following MMED’s separation from Medtronic.
- No per-share prices or cash values are reported (N/A). The awards were granted under MMED’s 2026 Long Term Incentive Plan and will vest on various future dates (see Key Details). This is an award/conversion (code A) — not an open-market purchase or sale.
Key Details
- Transaction date: March 11, 2026; Form 4 filed March 13, 2026 (appears timely).
- Total RSUs received: 191,258; price/value: N/A (conversion based on formulas tied to Medtronic and MMED average prices per the Employee Matters Agreement).
- Vesting schedule (varies by tranche): includes vesting on Dec 6, 2026; installments on Oct 28, 2026 / Oct 28, 2027 / Oct 29, 2028; Apr 30, 2027; Apr 28, 2028; Jul 31, 2026; Jul 29, 2027; and Jul 28, 2028.
- Awards resulted from the Equity Award Conversion following MMED’s March 9, 2026 separation from Medtronic (per Form 8-K and the EMA).
- Shares owned after the transaction are not specified in the Form 4. No 10b5-1 plan, tax-withholding sale, or late filing is indicated in the filing.
Context
- These are time-vesting RSUs converted from Medtronic awards due to a corporate separation, not discretionary open-market trades. RSUs vest over time and do not represent immediate sales or purchases; they are commonly used to preserve employee equity value through corporate transactions.
Insider Transaction Report
Form 4
Dianaty Ali
See Remarks
Transactions
- Award
Common Stock
[F1][F2][F3][F4]2026-03-11+11,054→ 11,054 total - Award
Common Stock
[F1][F2][F5][F4]2026-03-11+46,989→ 46,989 total - Award
Common Stock
[F1][F2][F6][F4]2026-03-11+35,448→ 35,448 total - Award
Common Stock
[F1][F2][F7][F4]2026-03-11+14,628→ 14,628 total - Award
Common Stock
[F1][F2][F8][F4]2026-03-11+33,684→ 33,684 total - Award
Common Stock
[F1][F2][F9][F4]2026-03-11+35,448→ 35,448 total - Award
Common Stock
[F1][F2][F10][F4]2026-03-11+11,563→ 11,563 total - Award
Common Stock
[F1][F2][F11][F4]2026-03-11+2,444→ 2,444 total
Footnotes (11)
- [F1]In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA").
- [F10]Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on December 6, 2026.
- [F11]Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest in three equal installments on October 28, 2026, October 28, 2027 and October 29, 2028.
- [F2]Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion").
- [F3]Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan (the "LTIP") and vest on December 6, 2026.
- [F4]Includes shares to be issued in connection with the vesting of one or more restricted stock units.
- [F5]Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on April 30, 2027.
- [F6]Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on April 28, 2028.
- [F7]Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 31, 2026.
- [F8]Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 29, 2027.
- [F9]Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 28, 2028.
Signature
/s/ Bryan F. Kelly, attorney-in-fact|2026-03-13